ESSA Pharma Inc. — Investor Relations & Filings
ESSA Pharma Inc. is a clinical-stage pharmaceutical company focused on the development of small molecule drugs for the treatment of prostate cancer. The company's core strategy is to develop novel therapies that target the N-terminal domain (NTD) of the androgen receptor (AR). This approach represents a distinct mechanism of action compared to existing treatments that target the ligand-binding domain of the AR. Its lead clinical candidate, EPI-7386, is an investigational oral drug designed to inhibit AR activity and is being developed for patients with castration-resistant prostate cancer (CRPC), including those whose disease has become resistant to current standard-of-care therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2025 | 2025-11-17 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| 15-12G | 2025-10-28 | English | |
| OWNERSHIP DOCUMENT | 2025-10-15 | English | |
| OWNERSHIP DOCUMENT | 2025-10-15 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12852931 | Regulatory Filings 2025 | 2025-11-17 | English | ||
| 12852932 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12852935 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12852934 | 15-12G | 2025-10-28 | English | ||
| 12852933 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852936 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852937 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852938 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852939 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852940 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852941 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852942 | POS AM | 2025-10-15 | English | ||
| 12852943 | S-8 POS | 2025-10-15 | English | ||
| 12852944 | S-8 POS | 2025-10-15 | English | ||
| 12852945 | S-8 POS | 2025-10-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ESSA Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35249/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35249 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35249 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35249 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35249}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ESSA Pharma Inc. (id: 35249)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.